WSJ News Exclusive | Catalent to Buy Supplement Maker Bettera Holdings for $1 Billion
Contract drug manufacturer Catalent Inc. is expected to announce Monday that it has agreed to buy closely held Bettera Holdings...
Contract drug manufacturer Catalent Inc. is expected to announce Monday that it has agreed to buy closely held Bettera Holdings...